Zobrazeno 1 - 10
of 725
pro vyhledávání: '"Assaf, K"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Yutaka Hatori, MD, PhD, Hiroyuki Sakai, MD, PhD, Tomoyuki Kunishima, MD, PhD, Nobuo Hatori, MD, PhD, Lin Chen, MD, Tomoaki Ishigami, MD, PhD, Naoki Satoh, MD, PhD, FJCC
Publikováno v:
Journal of Arrhythmia, Vol 33, Iss 2, Pp 111-116 (2017)
Background: Atrial fibrillation (AF) is one of the most prevalent cardiac arrhythmias associated with substantially increased risks of ischemic stroke and thromboembolism. Oral anticoagulants (OACs) are the cornerstone of AF management and effectivel
Externí odkaz:
https://doaj.org/article/1b7e7c4aab0c4befba43440a72d830e6
Autor:
Yutaka Hatori, Hiroyuki Sakai, Nobuo Hatori, Tomoyuki Kunishima, Atsuo Namiki, Makoto Shimizu, Nobuo Toyosaki, Masaomi Kuwajima, Naoki Sato
Publikováno v:
Journal of Cardiology. 81:385-389
Oral anticoagulant therapy for atrial fibrillation (AF) has changed dramatically. Direct oral anticoagulant (DOAC) therapy is administered by general practitioners and specialists. However, the beneficial long-term effects and safety of DOACs have no
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Lin Chen, Yutaka Hatori, Hiroyuki Sakai, Naoki Satoh, Nobuo Hatori, Tomoyuki Kunishima, Tomoaki Ishigami
Publikováno v:
Journal of Arrhythmia, Vol 33, Iss 2, Pp 111-116 (2017)
Journal of Arrhythmia
Journal of Arrhythmia
Background Atrial fibrillation (AF) is one of the most prevalent cardiac arrhythmias associated with substantially increased risks of ischemic stroke and thromboembolism. Oral anticoagulants (OACs) are the cornerstone of AF management and effectively
Publikováno v:
Journal of the American College of Cardiology. 75:2282
Anticoagulant therapy for atrial fibrillation (Af) has been dramatically changed in the era of therapy with direct oral anticoagulants (DOACs). The real-world status of patients with Af treated with warfarin or DOACs or without anti-coagulants is not
Autor:
Tilanus, R. P. J., Krichbaum, T. P., Zensus, J. A., Baudry, A., Bremer, M., Falcke, H., Giovannini, G., Laing, R., van Langevelde, H. J., Vlemmings, W., Abraham, Z., Afonso, J., Agudo, I., Alberdi, A., Alcolea, J., Altamirano, D., Asadi, S., Assaf, K., Augusto, P., Baczko, A-K., Boeck, M., Boller, T., Bondi, M., Boone, F., Bourda, G., Brajsa, R., Brand, J., Britzen, S., Bujarrabal, V., Cales, S., Casadio, C., Casasola, V., Castangia, P., Cernicharo, J., Charlot, P., Chemin, L., Clenet, Y., Colomer, F., Combes, F., Cordes, J., Coriat, M., Cross, N., D'Ammando, F., Dallacasa, D., Desmurs, J-F., Eatough, R., Eckart, A., Eisenacher, D., Etoka, S., Felix, M., Fender, R., Ferreira, M., Freeland, E., Frey, S., Fromm, C., Fuhrmann, L., Gabanyi, K., Galvan-Madrid, R., Giroletti, M., Goddi, C., Gomez, J., Gourgoulhon, E., Gray, M., di Gregorio, I., Greimel, R., Grosso, N., Guirado, J., Hada, K., Hanslmeier, A., Henkel, C., Herpin, F., Hess, P., Hodgson, J., Horns, D., Humphreys, E., Kramer, B. Hutawarakorn, Ilyushin, V., Impellizzeri, V., Ivanov, V., Julião, M., Kadler, M., Kerins, E., Klaassen, P., Klooster, K. van 't, Kording, E., Kozlov, M., Kramer, M., Kreikenbohm, A., Kurtanidze, O., Lazio, J., Leite, A., Leitzinger, M., Lepine, J., Levshakov, S., Lico, R., Lindqvist, M., Liuzzo, E., Lobanov, A., Lucas, P., Mannheim, K., Marcaide, J., Markoff, S., Martí-Vidal, I., Martins, C., Masetti, N., Massardi, M., Menten, K., Messias, H., Migliari, S., Mignano, A., Miller-Jones, J., Minniti, D., Molaro, P., Molina, S., Monteiro, A., Moscadelli, L., Mueller, C., Müller, A., Muller, S., Niederhofer, F., Odert, P., Olofsson, H., Orienti, M., Paladino, R., Panessa, F., Paragi, Z., Paumard, T., Pedrosa, P., Pérez-Torres, M., Perrin, G., Perucho, M., Porquet, D., Prandoni, I., Ransom, S., Reimers, D., Rejkuba, M., Rezzolla, L., Richards, A., Ros, E., Roy, A., Rushton, A., Savolainen, T., Schulz, R., Silva, M., Sivakoff, G., Soria-Ruiz, R., Soria, R., Spaans, M., Spencer, R., Stappers, B., Surcis, G., Tarchi, A., Temmer, M., Thompson, M., Torrelles, J., Truestedt, J., Tudose, V., Venturi, T., Verbiest, J., Vieira, J., Vielzeuf, P., Vincent, F., Wex, N., Wiik, K., Wiklind, T., Wilms, J., Zackrisson, E., Zechlin, H.
Very long baseline interferometry at millimetre/submillimetre wavelengths (mmVLBI) offers the highest achievable spatial resolution at any wavelength in astronomy. The anticipated inclusion of ALMA as a phased array into a global VLBI network will br
Externí odkaz:
http://arxiv.org/abs/1406.4650
Silicon monoxide maser emission has been detected in the circumstellar envelopes of many evolved stars in various vibrationally-excited rotational transitions. It is considered a good tracer of the wind dynamics close to the photosphere of the star.
Externí odkaz:
http://arxiv.org/abs/1302.2530
We present multi-epoch, total intensity, high-resolution images of 43GHz, v=1, J=1-0 SiO maser emission toward the Mira variable R Cas. In total we have 23 epochs of data for R Cas at approximate monthly intervals over an optical pulsation phase rang
Externí odkaz:
http://arxiv.org/abs/1105.1089
Autor:
Hatori, Yutaka1 (AUTHOR), Sakai, Hiroyuki1 (AUTHOR), Kunishima, Tomoyuki1 (AUTHOR), Chin, Keiichi1 (AUTHOR), Hatori, Nobuo1 (AUTHOR), Sato, Naoki1 (AUTHOR)
Publikováno v:
Journal of the American College of Cardiology (JACC). 2020 Supplement 1, Vol. 75, p2282-2282. 1p.